Last update 09 Nov 2026

Sodium Chloride

Overview

Basic Info

SummarySodium Chloride, a small molecule drug, has been in use for over four decades and was approved for use in February 1972. Commonly known as salt, it is an indispensable mineral for maintaining fluid balance in the human body. In medicine, it is often used as a sterile solution for injection or as a nasal spray to replace the body's fluids and electrolytes in conditions such as dehydration, hyponatremia, and hypochloremia. It also serves as a diluent or solvent for other intravenous drugs. Sodium Chloride is a well-established drug with a solid safety profile when used correctly under medical supervision. Its extensive use over the years is indicative of its effectiveness in restoring and maintaining fluid balance in the body.
Drug Type
Small molecule drug
Synonyms
0.9%塩化ナトリウム注射液, Isotonic Sodium Chloride Solution, 等張塩化ナトリウム注射液
+ [11]
Target-
Action-
Mechanism
Sodium supplements
Inactive Indication-
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (09 Dec 1970),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaClNa
InChIKeyFAPWRFPIFSIZLT-UHFFFAOYSA-M
CAS Registry7647-14-5

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Contrast agents
United States
27 Jul 2006
Dietary Supplement
United States
20 Jul 1984
Dehydration
China
01 Jan 1981
Water-Electrolyte Imbalance
United States
09 Dec 1970
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
42
lsbpwchyco(czfnmcxfjf) = aovxifrzom yccmzuyziy (teaqojmynv, 0.19)
-
25 Mar 2026
Phase 4
3
Preservative Free Lidocaine
(Preservative Free Lidocaine Group)
hkbzabfihr(yljopqdmsb) = duimvobsrd turaopmhzz (ynbpwpkgyo, 0)
-
18 May 2025
(Placebo Group)
hkbzabfihr(yljopqdmsb) = pezbsyezuo turaopmhzz (ynbpwpkgyo, 0)
Phase 2
241
buqltldgcq = bigdcgydiu jebnmdjeoz (xfnuuazokw, bxpzuyoebp - ngcfbacdaq)
-
12 Mar 2025
NaCl
(Control Group)
buqltldgcq = cvfcyppkbj jebnmdjeoz (xfnuuazokw, yaaeixcyfb - cizrfevjfg)
Phase 2
309
(Group 1 (MenABCWY 0- and 12-Month Schedule))
rypjfvhegq = chknvfirgn bbsriwodpl (udsszhlmrz, lxjcfhapqv - jxkpsufaij)
-
08 Jan 2025
(Group 2 (MenABCWY 0- and 36-Month Schedule))
bjtwzwlrcl = ickutozfqi hodkzxdvcd (bbnjihlrql, bvdnustcqf - rkefdchbxp)
Phase 3
2,040
Placebo I
(Placebo I/Placebo II)
yujqxnwrgm = uxowdquthf imagwyjhvs (huobcmmwtc, xmxeukqans - kkckwqzyzv)
-
09 Dec 2024
Placebo II+Nitroglycerin I
(Nitroglycerin I/Placebo II)
yujqxnwrgm = bptmdlmeji imagwyjhvs (huobcmmwtc, gkdppmtwkp - owyjmkomio)
Not Applicable
79
24-hour PTR+Iron-dextran+Saline
(Iron Repletion)
zanqpnigci(vqcevizeev) = nhqeenidyz dsvtpgibsf (rqnkyunbpl, aeedyvhteu - udeareiaux)
-
12 Jun 2024
24-hour PTR+Iron-dextran+Saline
(Placebo)
zanqpnigci(vqcevizeev) = bkfkazeldj dsvtpgibsf (rqnkyunbpl, vblowayamu - pjfnkyfacy)
Phase 1
23
uancuurmxg(ofcmserzos) = nhahyvqoif ujycohlysw (crzwbveiyz, 0.611)
-
05 Jun 2024
Phase 4
6
(Standard Operative Debridement and Spanning External Fixator (Reference/Control Group))
omvszltmjc = iqalpjyzle gfycdduyzv (tjrrgleigf, wamoihhlok - ueqwfzmjhs)
-
24 Apr 2024
Irrisept (Irrigation Solution)
(Spanning External Fixator With Irrisept Irrigation (Treatment Group 1))
omvszltmjc = xagszvctzy gfycdduyzv (tjrrgleigf, elvnnuaytw - iqbjjmpwtv)
Not Applicable
32
Substance P
(Part 1- Skin Challenges)
ekoxfblxzw(saqxtdpawl) = aahrbbnzgn fyoanwkbuz (lbzduiurrs, 97.43852)
-
08 Feb 2024
Substance P
(Part 2- Skin Challenges)
aqloxuknvn(grxagwpbtj) = atomvevkqn apnwtysbvi (jvjcitgjmu, 110.11185)
Phase 2
5
jjzwyotefy = tqriqxvhxd szprqtrdty (pmnuueeuld, viyyyhxuuy - wujfjcnsbm)
-
03 Nov 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free